Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-21

Clinical Trial Update: Salt-Sensitivity and Immunity Cell Activation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating salt-sensitivity and immune cell activation in hypertension. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: High Blood Pressure, Salt; Excess | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING